Evrysdi Disease Interactions
There is 1 disease interaction with Evrysdi (risdiplam).
Risdiplam (applies to Evrysdi) hepatic dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The pharmacokinetics and safety of risdiplam in patients with severe hepatic impairment (Child-Pugh class C) have not been studied. In patients with mild or moderate hepatic impairment, clinically meaningful differences have not been observed.
Switch to professional interaction data
Evrysdi drug interactions
There are 14 drug interactions with Evrysdi (risdiplam).
Report options
More about Evrysdi (risdiplam)
- Evrysdi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Spinraza
Spinraza is used to treat spinal muscular atrophy (SMA) in children and adults. It is administered ...
Zolgensma
Zolgensma (onasemnogene abeparvovec-xioi) is gene therapy used for spinal muscular atrophy. It is a ...
Onasemnogene abeparvovec
Onasemnogene abeparvovec systemic is used for spinal muscular atrophy
Nusinersen
Nusinersen is an intrathecal injection used to treat spinal muscular atrophy (SMA) in children and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
